Detalles de la búsqueda
1.
Glucose-lowering treatment patterns in patients with diabetic kidney disease.
Am J Manag Care
; 28(8): e301-e307, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35981131
2.
Real-World Effectiveness of Once-Weekly Semaglutide From a US Commercially Insured and Medicare Advantage Population.
Clin Ther
; 43(5): 808-821, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33785221
3.
Lifetime Cost-effectiveness of Oral Semaglutide Versus Dulaglutide and Liraglutide in Patients With Type 2 Diabetes Inadequately Controlled With Oral Antidiabetics.
Clin Ther
; 43(11): 1812-1826.e7, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34728099
4.
Determinants of delays in treatment initiation in children and adolescents diagnosed with leukemia or lymphoma in Canada.
Int J Cancer
; 126(8): 1936-1943, 2010 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19795458
5.
Impact of Weight Change in Adults with Type 2 Diabetes Mellitus: A Literature Review and Critical Analysis.
Clinicoecon Outcomes Res
; 12: 555-566, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33061488
6.
Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States.
Adv Ther
; 37(2): 869-882, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31925649
7.
Real-world Effectiveness of Liraglutide vs. Sitagliptin Among Older Patients with Type 2 Diabetes Enrolled in a Medicare Advantage Prescription Drug Plan: A Retrospective Observational Study.
Diabetes Ther
; 11(1): 213-228, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31820328
8.
Correction to: A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA.
Adv Ther
; 36(5): 1200, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30980280
9.
A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA.
Adv Ther
; 36(5): 1190-1199, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30875029
10.
Orally Administered Semaglutide Versus GLP-1 RAs in Patients with Type 2 Diabetes Previously Receiving 1-2 Oral Antidiabetics: Systematic Review and Network Meta-Analysis.
Diabetes Ther
; 10(6): 2183-2199, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31599391
11.
Effect of Weight Change on Economic Outcomes Among Persons with Type 2 Diabetes Mellitus in the United States: Beyond Glycemic Control.
J Manag Care Spec Pharm
; 25(6): 658-668, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30730232
12.
Evaluation of the Cost Per Patient Achieving Treatment Targets with Oral Semaglutide: A Short-Term Cost-Effectiveness Analysis in the United States.
Adv Ther
; 36(12): 3483-3493, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31650514
13.
Delays in diagnosis and treatment among children and adolescents with cancer in Canada.
Pediatr Blood Cancer
; 51(4): 468-74, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18454472
14.
Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years.
Diabetes Ther
; 9(3): 1279-1293, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29744818
15.
Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective.
Clinicoecon Outcomes Res
; 10: 791-803, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30532570
16.
Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States.
Diabetes Ther
; 9(3): 951-961, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29557057
17.
The Burden of Illness Related to Chronic Obstructive Pulmonary Disease Exacerbations in Québec, Canada.
Can Respir J
; 2017: 8184915, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28713217
18.
Polio vaccines, Simian Virus 40, and human cancer: the epidemiologic evidence for a causal association.
Oncogene
; 23(38): 6535-40, 2004 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-15322523
19.
Clinical, humanistic, and economic burden of chronic obstructive pulmonary disease (COPD) in Canada: a systematic review.
BMC Res Notes
; 8: 464, 2015 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-26391471
20.
Self-management and behaviour modification in COPD .
Patient Educ Couns
; 52(3): 271-7, 2004 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-14998597